16.05.2011 • NewsMichelinraw material pricesraw materials

Jean-Dominique Senard: Michelin Under Raw Material Pressure

 

French tire maker Michelin's next chief executive told a shareholders' meeting on Friday the company is facing "incredible pressure" from high and volatile raw materials prices.

"We have never experienced such strong pressure," Jean-Dominique Senard said, adding that despite the "incredible pressure" of raw materials the group's 2011 operating result would increase.

Senard also reiterated the long-term targets Michelin set out in October, including for operating profit before non-recurring items clearly above €2 billion ($2.84 billion) by 2015.

Michelin pledged in April to hike prices further to offset raw material costs. It said that over the next nine months it would increase prices to cover €400 million of 2011 cost headwinds, adding to previous increases covering €1.4 billion. Earlier this month, Michelin announced truck tire price rises to help offset the rising costs.

Rubber prices remain high despite recent falls from record levels.

Physical rubber prices have dropped more than 20% since hitting a record $6.40 per kilogram in February, driven by selling on the Tokyo Commodity Exchange and worries about a drop in demand from China as the world's largest consumer of rubber tightens the economy. In May 2010, physical rubber prices were at around $3 per kilo.

 

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

most read

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.

Photo
19.03.2025 • News

Arkema Launches Acrylic Acid Purification Project

Arkema has announced the launch of its Carat Project at its Carling site in France. This initiative aims to enhance the capabilities and sustainability of the facility, which specializes in producing acrylic monomers and superabsorbent polymers.

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.